Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Amortization of Deferred Charges (2017 - 2025)

Historic Amortization of Deferred Charges for Icu Medical (ICUI) over the last 9 years, with Q3 2025 value amounting to $1.6 million.

  • Icu Medical's Amortization of Deferred Charges fell 411.76% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 13.2%. This contributed to the annual value of $6.8 million for FY2024, which is 10.27% down from last year.
  • According to the latest figures from Q3 2025, Icu Medical's Amortization of Deferred Charges is $1.6 million, which was down 411.76% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Amortization of Deferred Charges peaked at $1.9 million during Q2 2022, and registered a low of $24000.0 during Q4 2021.
  • For the 5-year period, Icu Medical's Amortization of Deferred Charges averaged around $1.4 million, with its median value being $1.7 million (2023).
  • As far as peak fluctuations go, Icu Medical's Amortization of Deferred Charges tumbled by 9691.25% in 2021, and later skyrocketed by 705833.33% in 2022.
  • Icu Medical's Amortization of Deferred Charges (Quarter) stood at $24000.0 in 2021, then soared by 7058.33% to $1.7 million in 2022, then decreased by 0.7% to $1.7 million in 2023, then dropped by 0.59% to $1.7 million in 2024, then dropped by 3.89% to $1.6 million in 2025.
  • Its Amortization of Deferred Charges was $1.6 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.7 million in Q1 2025.